Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06654245 · ClinicalTrials.gov registry record · NA
Assessing and Addressing Follow-up Care Needs That Will Facilitate Care Transitions for Cancer Survivors
A NA study, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT06654245 is a NA study that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 5 participants.
The verdict
NCT06654245, a NA study, was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This clinical trial evaluates whether a shared response plan (SHAREDCare) improves follow-up care for lung cancer survivors. As the number of cancer survivors increases, there is a new need for high-quality chronic illness care. High-quality chronic illness care can be difficult to deliver and involves working with the patient to be certain they have what they need to be actively involved with their care to meet their needs. SHAREDCare allows the patient to work with a navigator to review identified distress and social needs. The patient and navigator discuss the needs and develop a shared response plan to address the needs in ways that consider the patient's current behaviors, beliefs, and motivation. The plan also establishes specific patient goals, anticipates barriers, and establishes how the navigator will follow-up on the needs and adjust care and assistance when needed. Using a shared response plan may improve follow-up care for lung cancer survivors.
Interventions
- OTHER Survey using a questionnaire.
- OTHER Electronic health record review
- OTHER Referral
- BEHAVIORAL Telephone based interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2025-06-11 |
| Est. Completion | 2026-01-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06654245
The ClinicalTrials.gov registry entry for NCT06654245 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Survey using a questionnaire. is the first listed.
NCT06654245 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06654245 about?
NCT06654245 is a clinical study titled "Assessing and Addressing Follow-up Care Needs That Will Facilitate Care Transitions for Cancer Survivors". This clinical trial evaluates whether a shared response plan (SHAREDCare) improves follow-up care for lung cancer survivors. As the number of cancer survivors increases, there is a new need for high-quality chronic illness care. High-quality chronic illness care can be difficult to deliver and invol...
What is the current status of trial NCT06654245?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2025-06-11. Estimated completion is 2026-01-12.
What interventions are being tested in trial NCT06654245?
The interventions under investigation include: Survey using a questionnaire. (OTHER), Electronic health record review (OTHER), Referral (OTHER), Telephone based interview (BEHAVIORAL).
Who is sponsoring clinical trial NCT06654245?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.